Beyond ECMO: The Shock Team and Mechanical Circulatory Support in the Cardiothoracic ICU

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Rita Milewski, MD, PhD
Disclosure(s): Destiny Pharmaca: Advisory Board (Ongoing)

Jeffrey Javidfar, MD

Nicholas Teman, MD

Presentations

  1. How to Organize and Develop a Shock Team
    Michael Zacharias, DO, FHFSA, FACC
     
  2. Understanding Clinical Trajectory of Patients Developing Postcardiotomy Cardiogenic Shock -- Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database
    Nicolas A. Brozzi, MD
    Disclosure(s): Abiomed Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Fresenius Medical Care North America: Speaker (Ongoing)
     
  3. Role of the ECMO Team in Managing CT ICU Patients
    Casey Miller, NP
    Disclosure(s): Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  4. Building Bridges: How to Transition from ECMO to Alternative Temporary Modalities
    Christian A. Bermudez, MD
    Disclosure(s): Abbot: Advisory Board (Ongoing); Abiomed Breethe: Advisory Board (Ongoing)
     
  5. Biventricular Percutaneous VAD Support
    Amy E. Hackmann, MD
    Disclosure(s): Medtronic: Advisory Board (Ongoing), Speaker (Ongoing); Abbott Inc.: Consultant (Ongoing), Speaker (Ongoing)
     
  6. The Benefits and Costs of Regionalization: Clinical and Financial Outcomes of Cardiogenic Shock at Cardiac Surgery Specialized Hospitals
    Amulya Vadlakonda
     
  7. Case Presentation
    Sameer Hirji, MD MPH
Activity summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Rita Milewski, MD, PhD
Disclosure(s): Destiny Pharmaca: Advisory Board (Ongoing)

Jeffrey Javidfar, MD

Nicholas Teman, MD

Presentations

  1. How to Organize and Develop a Shock Team
    Michael Zacharias, DO, FHFSA, FACC
     
  2. Understanding Clinical Trajectory of Patients Developing Postcardiotomy Cardiogenic Shock -- Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database
    Nicolas A. Brozzi, MD
    Disclosure(s): Abiomed Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Fresenius Medical Care North America: Speaker (Ongoing)
     
  3. Role of the ECMO Team in Managing CT ICU Patients
    Casey Miller, NP
    Disclosure(s): Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  4. Building Bridges: How to Transition from ECMO to Alternative Temporary Modalities
    Christian A. Bermudez, MD
    Disclosure(s): Abbot: Advisory Board (Ongoing); Abiomed Breethe: Advisory Board (Ongoing)
     
  5. Biventricular Percutaneous VAD Support
    Amy E. Hackmann, MD
    Disclosure(s): Medtronic: Advisory Board (Ongoing), Speaker (Ongoing); Abbott Inc.: Consultant (Ongoing), Speaker (Ongoing)
     
  6. The Benefits and Costs of Regionalization: Clinical and Financial Outcomes of Cardiogenic Shock at Cardiac Surgery Specialized Hospitals
    Amulya Vadlakonda
     
  7. Case Presentation
    Sameer Hirji, MD MPH